HIGHLIGHTS
- who: Implantable cardioverter defibrillator . et al. from the implantation in the Erasmus MC, Rotterdam, the Netherlands and the University Hospital, Basel, SwitzerlandKaplanMeier survival analysis was performed, and mortality predictors were identified. Mortality of the cohort was compared have published the research work: ICDs at higher age and clinical risk factors, in the Journal: (JOURNAL)
- what: Elderly patients, as selected in our hospitals, still have an acceptable survival, independent of prevention indication and therefore can still benefit from ICD therapy.
SUMMARY
Both in primary prevention and secondary prevention trials, there has been . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.